Hospira Inc (NYSE:HSP)

88.95
Delayed Data
As of Jul 02
 +0.06 / +0.07%
Today’s Change
46.56
Today|||52-Week Range
88.99
+45.22%
Year-to-Date
Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog
Jun 30 / Zacks.com
Boston Scientific Initiates Global Study on Emblem S-ICD - Analyst Blog
Jun 24 / Zacks.com
Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog
Jun 30 / Zacks.com
Pfizer Starts Phase III Rivipansel Study, GlycoMimetics Up - Analyst Blog
Jun 24 / Zacks.com
Zimmer-Biomet Merger Completes, 2015 Guidance Updated - Analyst Blog
Jun 29 / Zacks.com
The Medicines Co. Antiplatelet Drug Kengreal Wins FDA Nod - Analyst Blog
Jun 23 / Zacks.com
Biogen/Sobi's Hemophilia B Drug Alprolix under EU Review - Analyst Blog
Jun 29 / Zacks.com
Medtronic Buys Aptus Endosystems, Strengthens EVAR Base - Analyst Blog
Jun 23 / Zacks.com
Eli Lilly Wins Alimta Patent Lawsuit in the UK, Shares Up - Analyst Blog
Jun 26 / Zacks.com
Medtronic Micra TPS Pacemaker Meets Initial Safety Levels - Analyst Blog
Jun 23 / Zacks.com
Medtronic Recalls Faulty Tracheostomy Tubes, Stock Down - Analyst Blog
Jun 26 / Zacks.com
Bristol-Myers' (BMY) Melanoma Drug Opdivo Gets EU Nod - Analyst Blog
Jun 22 / Zacks.com
Agios Doses First Patient with AG-881 in Early-Stage Study - Analyst Blog
Jun 25 / Zacks.com
Medtronic Hikes Dividend by 25%, Plans 80M in Buyback - Analyst Blog
Jun 22 / Zacks.com
Medtronic's CoreValve Evolut R TAVR System Wins FDA Nod - Analyst Blog
Jun 25 / Zacks.com
Medtronic Expands AF Menu with CardioInsight Acquisition - Analyst Blog
Jun 22 / Zacks.com
Rockwell Medical (RMTI) Worth Watching: Stock Up 11.3% - Tale of the Tape
Jun 25 / Zacks.com
A hacker can give you a fatal overdose
Jun 10 / CNNMoney.com
Synergy Pharmaceuticals' Plecanatide in 2nd IBS-C study - Analyst Blog
Jun 24 / Zacks.com
South Korea pushes to be new force in pharma
Jun 10 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account